PDL BioPharma Stock Price, News & Analysis

PDLI NASDAQ

Company Description

PDL BioPharma (NASDAQ: PDLI) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.

PDLI stock has declined 24.0% over the past year.

This page provides a comprehensive overview of PDLI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-24%

Performance 1 year

$0.0

Market Cap

114.2M

Shares outstanding

PDL BioPharma (PDLI) stock. Over the past 12 months, the stock has lost 24.0%.

Latest News

View All

December 14, 2020

+5.20%

PDL BioPharma Enters into $51.4 Million Capital Provision Agreement with Epps Investments LLC Regarding PDL's Previously Announced Settlement Agreement with Wellstat

December 8, 2020

-4.67%

PDL Announces Timeline for Voluntarily Delisting from Nasdaq

November 11, 2020

+1.77%

PDL BioPharma Reports 2020 Third Quarter Financial Results and Sets Date To File a Certificate of Dissolution

earnings

November 6, 2020

-3.13%

PDL BioPharma Reschedules Third Quarter 2020 Financial Results and Business Update

earnings

October 29, 2020

0.00%

PDL BioPharma to Announce Third Quarter 2020 Financial Results and Provide a Business Update on November 9, 2020

earnings

October 2, 2020

-18.94%

PDL BioPharma Completes Spin-Off of LENSAR

PDL BioPharma has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings. View all PDLI news →

SEC Filings

View All

No SEC filings available for PDLI.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

PDLI Company Profile & Sector Positioning

PDL BioPharma (PDLI) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.